FDA Adverse Event
Injury
Summary report: N
LINEAR 3-4
MDR report key: 21050393
·
Received December 31, 2024
Report
- Report Number
- 3006630150-2024-09180
- Event Type
- Injury
- Date Received
- December 31, 2024
- Date of Event
- October 29, 2024
- Report Date
- December 31, 2024
- Manufacturer
- BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
- Product Code
- LGW
- UDI-DI
- 08714729789550
- PMA / PMN Number
- P030017
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Additional Manufacturer Narrative · 0
ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: BRAND NAME: LINEAR 3-4 UPN: M365SC2352500 MODEL: SC-2352-50 SERIAL: (B)(6). BATCH: 7080068.
Description of Event or Problem · 0
IT WAS REPORTED THAT FOLLOWING A LEAD REVISION PROCEDURE (SEE MFR. REPORT 3006630150-2024-07951) THE PATIENT DEVELOPED A STAPHYLOCOCCUS AUREUS INFECTION AT THE SPINAL CORD STIMULATION LEAD SITE. THE PATIENT UNDERWENT A LEAD EXPLANT PROCEDURE, WAS ADMINISTERED FLUCLOXACILLIN, AND WAS DOING WELL POSTOPERATIVELY. THE PHYSICIAN ASSESSED THE INFECTION WAS DEVICE RELATED. THE DEVICES WERE NOT RETURNED AS THEY WERE RETAINED BY THE MEDICAL FACILITY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2525959 | LINEAR 3-4 | STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF | LGW | BOSTON SCIENTIFIC NEUROMODULATION CORPORATION | SC-2352-50 | 7081959 | 08714729789550 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 31 YR | Male | Required Intervention |